Cyclooxygenase inhibitor ketorolac or mast cell stabilizers: immunologic challenges in cancer therapy
- PMID: 15709209
Cyclooxygenase inhibitor ketorolac or mast cell stabilizers: immunologic challenges in cancer therapy
Comment on
-
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia.Clin Cancer Res. 2004 Mar 1;10(5):1565-73. doi: 10.1158/1078-0432.ccr-1020-3. Clin Cancer Res. 2004. PMID: 15014005 Clinical Trial.